GHRP-6 (Growth Hormone–Releasing Peptide-6) is a synthetic peptide that stimulates the release of growth hormone (GH) from the pituitary gland. It works by activating the ghrelin receptor, which strongly increases appetite in addition to GH secretion. GHRP-6 produces short, natural-like pulses of growth hormone rather than continuous elevation. It is often used to support muscle recovery, fat loss, and improved sleep quality. A notable side effect is intense hunger, especially shortly after dosing. GHRP-6 is typically administered by subcutaneous injection multiple times daily. It is not approved for medical use and is classified as a research peptide.
Dosing GHRP-6
GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a). It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits. This educational protocol presents a three-times-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements. Reconstitute: Add 3.0 mL bacteriostatic water -3.33 mg/mL concentration. Typical daily range: 300–900 mcg total (split into 3 doses with gradual titration).
GHRP-6 / 10 MG
Short Description:
GHRP-6 (Growth Hormone–Releasing Peptide-6) is a synthetic peptide that stimulates the release of growth hormone (GH) from the pituitary gland. It works by activating the ghrelin receptor, which strongly increases appetite in addition to GH secretion. GHRP-6 produces short, natural-like pulses of growth hormone rather than continuous elevation. It is often used to support muscle recovery, fat loss, and improved sleep quality. A notable side effect is intense hunger, especially shortly after dosing. GHRP-6 is typically administered by subcutaneous injection multiple times daily. It is not approved for medical use and is classified as a research peptide.


Reviews
There are no reviews yet.